Treatment Recommendations for Brucellosis
Author Information
Author(s): Javier Ariza, Mile Bosilkovski, Antonio Cascio, Juan D. Colmenero, Michael J. Corbel, Matthew E. Falagas, Ziad A. Memish, Mohammad Reza Hasanjani Roushan, Ethan Rubinstein, Nikolaos V. Sipsas, Javier Solera, Edward J. Young, Georgios Pappas
Hypothesis
What is the optimal treatment regimen for human brucellosis?
Conclusion
The study provides evidence-based recommendations for treating brucellosis, emphasizing the need for a combination of doxycycline with either streptomycin or rifampicin.
Supporting Evidence
- Brucellosis is the most common anthropozoonotic infection worldwide.
- The WHO recommended regimens for brucellosis treatment have not been universally applied.
- Relapses occur in 5% to 15% of uncomplicated cases, indicating the need for effective treatment strategies.
- Prolonged treatment reduces the risk of relapse.
- Emerging antimicrobial resistance poses challenges for treatment in endemic regions.
Takeaway
Brucellosis is a common infection that needs careful treatment with specific antibiotics to avoid relapses.
Methodology
The authors reviewed existing literature and conducted a consensus meeting to develop treatment recommendations.
Potential Biases
Potential biases may arise from the authors' affiliations and the selection of studies reviewed.
Limitations
The recommendations are based on existing studies, which may have varying quality and design.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website